Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 12
Submit an article Journal homepage
3,327
Views
71
CrossRef citations to date
0
Altmetric
Original Research

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

Magnus PedersenCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
,
Marie Christine Wulff WestergaardCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
,
Katy MilneDeeley Research Centre, BC Cancer, Victoria, CanadaView further author information
,
Morten NielsenCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkORCID Iconhttp://orcid.org/0000-0002-1250-4885View further author information
ORCID Icon,
Troels Holz BorchCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkORCID Iconhttp://orcid.org/0000-0002-4402-9281View further author information
ORCID Icon,
Lars Grønlund PoulsenDepartment of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
,
Helle Westergren HendelDepartment of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
,
Mia KennedyDeeley Research Centre, BC Cancer, Victoria, CanadaView further author information
,
Gillian BriggsDeeley Research Centre, BC Cancer, Victoria, CanadaView further author information
,
Stacey LedouxDeeley Research Centre, BC Cancer, Victoria, CanadaView further author information
,
Trine Jakobi NøttrupDepartment of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkView further author information
,
Pernille AndersenDepartment of Clinical Immunology and Stem Cell Facility, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
,
Thomas HasselagerDepartment of Pathology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
,
Özcan MetCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkORCID Iconhttp://orcid.org/0000-0002-3256-7592View further author information
ORCID Icon,
Brad H. NelsonDeeley Research Centre, BC Cancer, Victoria, Canada;Department of Medical Genetics, University of British Columbia, Vancouver, CanadaView further author information
,
Marco DoniaCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkView further author information
&
Inge Marie SvaneCenter for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DenmarkCorrespondence[email protected]
View further author information
 show all
Article: e1502905 | Received 11 Apr 2018, Accepted 16 Jul 2018, Published online: 26 Sep 2018

Citations (71)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Yahui Zhu, Jing Zhou, Lijing Zhu, Wenjing Hu, Baorui Liu & Li Xie. (2022) Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer. Human Vaccines & Immunotherapeutics 18:5.
Read now
Rebecca C. Arend, Amy Jackson-Fisher, Ira A. Jacobs, Jeffrey Chou & Bradley J. Monk. (2021) Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease. Cancer Biology & Therapy 22:2, pages 89-105.
Read now
Teng Wei, Matthias Leisegang, Ming Xia, Kazuma Kiyotani, Ning Li, Chenquan Zeng, Chunyan Deng, Jinxing Jiang, Makiko Harada, Nishant Agrawal, Liangping Li, Hui Qi, Yusuke Nakamura & Lili Ren. (2021) Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma. OncoImmunology 10:1.
Read now
Innocenza Palaia, Federica Tomao, Carolina Maria Sassu, Lucia Musacchio & Pierluigi Benedetti Panici. (2020) Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches. OncoTargets and Therapy 13, pages 6109-6129.
Read now

Articles from other publishers (67)

Milena Kalaitsidou, Owen R. Moon, Martina Sykorova, Leyuan Bao, Yun Qu, Sujita Sukumaran, Michael Valentine, Xingliang Zhou, Veethika Pandey, Kay Foos, Sergey Medvedev, Daniel J. Powell Jr, Akshata Udyavar, Eric Gschweng, Ruben Rodriguez, Mark E. Dudley, Robert E. Hawkins, Gray Kueberuwa & John S. Bridgeman. (2023) Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes. Frontiers in Immunology 14.
Crossref
Els M E Verdegaal, Saskia J Santegoets, Marij J P Welters, Linda de Bruin, Marten Visser, Caroline E van der Minne, Pita M de Kok, Nikki M Loof, Sanne Boekestijn, Inge Roozen, Inge M Westra, Pauline Meij, Sjoerd H Van der Burg & Judith R Kroep. (2023) Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer. Journal for ImmunoTherapy of Cancer 11:11, pages e007697.
Crossref
D. C. A. Quixabeira, E. Jirovec, S. Pakola, R. Havunen, S. Basnet, J. M. Santos, T. V. Kudling, J. H. A. Clubb, L. Haybout, V. Arias, S. Grönberg-Vähä-Koskela, V. Cervera-Carrascon, A. Pasanen, M. Anttila, J. Tapper, A. Kanerva & A. Hemminki. (2023) Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. Cancer Gene Therapy 30:11, pages 1543-1553.
Crossref
T ZEMANEK, Z NOVA & A NICODEMOU. (2023) Tumor-Infiltrating Lymphocytes and Adoptive Cell Therapy: State of the Art in Colorectal, Breast and Lung Cancer. Physiological Research 72:S3, pages S209-S224.
Crossref
Sara Bobisse, Valentina Bianchi, Janos L. Tanyi, Apostolos Sarivalasis, Edoardo Missiaglia, Rémy Pétremand, Fabrizio Benedetti, Drew A. Torigian, Raphael Genolet, David Barras, Alexandra Michel, Spyridon A. Mastroyannis, Emese Zsiros, Denarda Dangaj Laniti, Zoi Tsourti, Brian J. Stevenson, Christian Iseli, Bruce L. Levine, Daniel E. Speiser, David Gfeller, Michal Bassani-Sternberg, Daniel J. PowellJrJr, Carl H. June, Urania Dafni, Lana E. Kandalaft, Alexandre Harari & George Coukos. (2023) A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer. Nature Cancer 4:10, pages 1410-1417.
Crossref
Zikun Peng, Ming Li, Huayi Li & Qinglei Gao. (2023) PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities. Drug Discovery Today 28:8, pages 103666.
Crossref
Hyun Lee, Kwanghee Kim, Jiwon Chung, Mofazzal Hossain & Hee Jin Lee. (2023) Tumor‐infiltrating lymphocyte therapy: Clinical aspects and future developments in this breakthrough cancer treatment. BioEssays 45:7.
Crossref
V. N. Zhurman & E. V. Eliseeva. (2023) Vaccination strategies and adoptive immunotherapy for ovarian cancer. Literature review. Hirurg (Surgeon):3, pages 58-64.
Crossref
Víctor Albarrán, María Luisa Villamayor, Javier Pozas, Jesús Chamorro, Diana Isabel Rosero, María San Román, Patricia Guerrero, Patricia Pérez de Aguado, Juan Carlos Calvo, Coral García de Quevedo, Carlos González & María Ángeles Vaz. (2023) Current Landscape of Immunotherapy for Advanced Sarcoma. Cancers 15:8, pages 2287.
Crossref
Ammarina Beumer‐Chuwonpad, Floris P.J. van Alphen, Natasja A.M. Kragten, Julian J. Freen‐van Heeren, Maria Rodriguez Gomez, Arthur J. Verhoeven, Maartje van den Biggelaar & Klaas P.J.M. van Gisbergen. (2022) Memory CD8 + T cells upregulate glycolysis and effector functions under limiting oxygen conditions . European Journal of Immunology 53:2.
Crossref
V.V. Saevets, A.Yu. Shamanova, A.A. Mukhin, L.V. Yarina, A.V. Taratonov & V.M. Vlasova. (2023) Approaches to therapy for ovarian cancer yesterday, today, tomorrow. Onkologiya. Zhurnal imeni P.A.Gertsena 12:4, pages 67.
Crossref
Timothy D. Folsom, Branden S. Moriarity, Timothy K. Starr, Emil Lou & Beau R. Webber. 2023. NK Cells in Cancer Immunotherapy: Successes and Challenges. NK Cells in Cancer Immunotherapy: Successes and Challenges 403 426 .
Farbod Ghobadinezhad, Zhila Izadi, Marzieh Ebrahimi & Nima Rezaei. 2023.
Tianyue Xu, Zhihui Liu, Liwen Huang, Jing Jing & Xiaowei Liu. (2022) Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy. Frontiers in Immunology 13.
Crossref
Lana E. Kandalaft, Denarda Dangaj Laniti & George Coukos. (2022) Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nature Reviews Cancer 22:11, pages 640-656.
Crossref
Esther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Dahlstrand & Isabelle Magalhaes. (2022) Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Seminars in Cancer Biology 86, pages 207-223.
Crossref
Mohammad Hossein Kazemi, Maryam Sadri, Alireza Najafi, Ali Rahimi, Zeinab Baghernejadan, Hossein Khorramdelazad & Reza Falak. (2022) Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?. Frontiers in Immunology 13.
Crossref
S.M. Castenmiller, R. de Groot, A. Guislain, K. Monkhorst, K.J. Hartemink, A.A.F.A. Veenhof, E.F. Smit, J.B.A.G. Haanen & M.C. Wolkers. (2022) Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments. Immuno-Oncology and Technology 15, pages 100090.
Crossref
Aarushi Audhut Caro, Sofie Deschoemaeker, Lize Allonsius, An Coosemans & Damya Laoui. (2022) Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer. Cancers 14:16, pages 4037.
Crossref
Jitka Fucikova, Michal Hensler, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Jana Rakova, Jana Drozenova, Tessa Fredriksen, Marek Hraska, Tereza Hrnciarova, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Pavel Dundr, Jan Laco, Tomas Brtnicky, Ivan Praznovec, Michael J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, David Cibula, Jirina Bartunkova, Jérôme Galon, Lorenzo Galluzzi & Radek Spisek. (2022) An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors. Clinical Cancer Research 28:14, pages 3053-3065.
Crossref
Yuedi Zhang, Qiulin Cui, Manman Xu, Duo Liu, Shuzhong Yao & Ming Chen. (2022) Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer. Frontiers in Immunology 13.
Crossref
Ji Son, Goldy C. George, Mirella Nardo, Kate J. Krause, Amir A. Jazaeri, Amadeo B. Biter & David S. Hong. (2022) Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis. Gynecologic Oncology 165:3, pages 664-670.
Crossref
Susan M. Lang & Oliver Dorigo. (2022) Cell-based immunotherapies in gynecologic cancers. Current Opinion in Obstetrics & Gynecology 34:1, pages 10-14.
Crossref
Virginie Bund, Henri Azaïs, Sabrina Bibi-Triki, Lise Lecointre, Sarah Bétrian Betrian, Martina Aida Angeles, Lauriane Eberst, Emilie Faller, Thomas Boisramé, Sofiane Bendifallah, Chérif Akladios & Élise Deluche. (2022) Basics of immunotherapy for epithelial ovarian cancer. Journal of Gynecology Obstetrics and Human Reproduction 51:2, pages 102283.
Crossref
K.S. Saini, I.M. Svane, M. Juan, F. Barlesi & F. André. (2022) Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges. Annals of Oncology 33:1, pages 6-12.
Crossref
Jesse Demuytere, Sam Ernst, Judith van Ovost, Sarah Cosyns & Wim Ceelen. 2022. Cellular Immunity in the Peritoneum. Cellular Immunity in the Peritoneum 63 95 .
Premal H. Thaker & Anil K. Sood. 2022. Comprehensive Gynecology. Comprehensive Gynecology 606 617.e3 .
Shaina F. Bruce & Matthew A. Powell. (2022) The Use of Targeted Agents in the Treatment of Gynecologic Cancers. Current Treatment Options in Oncology 23:1, pages 15-28.
Crossref
Diana C. DeLucia & John K. Lee. 2022. Cancer Immunotherapies. Cancer Immunotherapies 1 48 .
Racheal Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick de Jong & Nicolas Orsi. (2021) Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment. Cancers 13:24, pages 6231.
Crossref
Janina Świderska, Mateusz Kozłowski, Sebastian Kwiatkowski & Aneta Cymbaluk-Płoska. (2021) Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points. Cancers 13:23, pages 6063.
Crossref
Julien Edeline, Roch Houot, Aurélien Marabelle & Marion Alcantara. (2021) CAR-T cells and BiTEs in solid tumors: challenges and perspectives. Journal of Hematology & Oncology 14:1.
Crossref
Claudia Marchetti, Francesca De Felice, Alessia Romito, Valentina Iacobelli, Carolina Maria Sassu, Giacomo Corrado, Caterina Ricci, Giovanni Scambia & Anna Fagotti. (2021) Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments. Seminars in Cancer Biology 77, pages 144-166.
Crossref
Olivia Le Saux, Isabelle Ray-Coquard & S. Intidhar Labidi-Galy. (2021) Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer. Seminars in Cancer Biology 77, pages 127-143.
Crossref
Maria Poplawska, Dibyendu Dutta, Yichun Lee & Seah H. Lim. (2021) Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering. Molecular Therapy - Oncolytics 23, pages 378-386.
Crossref
Anders Handrup Kverneland, Christopher Aled Chamberlain, Troels Holz Borch, Morten Nielsen, Sofie Kirial Mørk, Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Lise Pyndt Jørgensen, Lene Buhl Riis, Christina Westmose Yde, Özcan Met, Marco Donia & Inge Marie Svane. (2021) Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types. Journal for ImmunoTherapy of Cancer 9:10, pages e003499.
Crossref
Jitka Fucikova, An Coosemans, Sandra Orsulic, David Cibula, Ignace Vergote, Lorenzo Galluzzi & Radek Spisek. (2021) Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for ImmunoTherapy of Cancer 9:10, pages e002873.
Crossref
Holger Bronger. (2021) Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects. Geburtshilfe und Frauenheilkunde 81:10, pages 1128-1144.
Crossref
Xiaoyun Li, Jingling Tang, Hang Du, Xinjun Wang, Liyun Wu, Pingsheng Hu, Hua Zhang, Ruyi Zhang & Yuan Yang. (2021) Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients. Journal of Immunology Research 2021, pages 1-11.
Crossref
Anders H. Kverneland, Troels Holz Borch, Joachim Granhøj, Henrik Sengeløv, Marco Donia & Inge Marie Svane. (2021) Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition. Cytotherapy 23:8, pages 724-729.
Crossref
Mira Hoteit, Zeina Oneissi, Ranim Reda, Fadi Wakim, Amar Zaidan, Mohammad Farran, Eli Abi‑Khalil & Mirvat El‑Sibai. (2021) Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review). Oncology Letters 22:3.
Crossref
Thomas Morgan Hulen, Christopher Aled Chamberlain, Inge Marie Svane & Özcan Met. (2021) ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors. Immuno 1:3, pages 194-211.
Crossref
Chantal Saberian, Rodabe N. Amaria, Amer M. Najjar, Laszlo G. Radvanyi, Cara L. Haymaker, Marie-Andrée Forget, Roland L. Bassett, Silvana C. Faria, Isabella C. Glitza, Enrique Alvarez, Sapna Parshottam, Victor Prieto, Gregory Lizée, Michael K. Wong, Jennifer L. McQuade, Adi Diab, Cassian Yee, Hussein A. Tawbi, Sapna Patel, Elizabeth J. Shpall, Michael A. Davies, Patrick Hwu & Chantale Bernatchez. (2021) Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. Journal for ImmunoTherapy of Cancer 9:5, pages e002449.
Crossref
Abraham Nissani, Shaked Lev-Ari, Tomer Meirson, Elad Jacoby, Nethanel Asher, Guy Ben-Betzalel, Orit Itzhaki, Ronnie Shapira-Frommer, Jacob Schachter, Gal Markel & Michal J. Besser. (2021) Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy. Journal for ImmunoTherapy of Cancer 9:5, pages e001743.
Crossref
Diego Salas-Benito, Enrique Conde, Ibon Tamayo-Uria, Uxua Mancheño, Edurne Elizalde, David Garcia-Ros, Jose M. Aramendia, Juan C. Muruzabal, Julia Alcaide, Francisco Guillen-Grima, Jose A. Minguez, Jose Amores-Tirado, Antonio Gonzalez-Martin, Pablo Sarobe, Juan J. Lasarte, Mariano Ponz-Sarvise, Carlos E. De Andrea & Sandra Hervas-Stubbs. (2021) The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes. British Journal of Cancer 124:6, pages 1138-1149.
Crossref
Mayu Ukai, Akira Yokoi, Kosuke Yoshida, Shiro Suzuki, Kiyosumi Shibata, Fumitaka Kikkawa, Tetsuya Nakatsura & Hiroaki Kajiyama. (2021) Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma. Cancers 13:3, pages 550.
Crossref
Apostolos Sarivalasis, Matteo Morotti, Arthur Mulvey, Martina Imbimbo & George Coukos. (2021) Cell therapies in ovarian cancer. Therapeutic Advances in Medical Oncology 13, pages 175883592110083.
Crossref
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy 485 514 .
Jeffrey A. How, Ami Patel & Amir A. Jazaeri. 2021. Immunotherapy. Immunotherapy 193 232 .
Marie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, Thomas Hasselager, Lars Rønn Olsen, Michael S. Anglesio, Troels Holz Borch, Mia Kennedy, Gillian Briggs, Stacey Ledoux, Caroline Kreuzinger, Isabel von der Decken, Marco Donia, Dan Cacsire Castillo-Tong, Brad H. Nelson & Inge Marie Svane. (2020) Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer. Cancers 12:12, pages 3828.
Crossref
Philippe O. Gannon, Alexandre Harari, Aymeric Auger, Clément Murgues, Vincent Zangiacomi, Olivier Rubin, Kim Ellefsen Lavoie, Laurent Guillemot, Blanca Navarro Rodrigo, Tu Nguyen-Ngoc, Sylvie Rusakiewicz, Laetitia Rossier, Caroline Boudousquié, Petra Baumgaertner, Stefan Zimmermann, Lionel Trueb, Emanuela M. Iancu, Christine Sempoux, Nicolas Demartines, George Coukos & Lana E. Kandalaft. (2020) Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment. Cytotherapy 22:12, pages 780-791.
Crossref
Aishwarya Gokuldass, Arianna Draghi, Krisztian Papp, Troels Holz Borch, Morten Nielsen, Marie Christine Wulff Westergaard, Rikke Andersen, Aimilia Schina, Kalijn Fredrike Bol, Christopher Aled Chamberlain, Mario Presti, Özcan Met, Katja Harbst, Martin Lauss, Samuele Soraggi, Istvan Csabai, Zoltán Szállási, Göran Jönsson, Inge Marie Svane & Marco Donia. (2020) Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma. Cancers 12:11, pages 3344.
Crossref
Dirk M. Zajonc. (2020) Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation. International Journal of Molecular Sciences 21:20, pages 7561.
Crossref
Chiara Napoletano, Catharina Steentoff, Federico Battisti, Zilu Ye, Hassan Rahimi, Ilaria Grazia Zizzari, Marco Dionisi, Bruna Cerbelli, Federica Tomao, Deborah French, Giulia d’Amati, Pierluigi Benedetti Panici, Sergey Vakhrushev, Henrik Clausen, Marianna Nuti & Aurelia Rughetti. (2020) Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL). Cancers 12:10, pages 2841.
Crossref
Michal J. Besser, Orit Itzhaki, Guy Ben‐Betzalel, Douglas B. Zippel, Dragoslav Zikich, Adva Kubi, Karin Brezinger, Abraham Nissani, Michal Levi, Li‐at Zeltzer, Alon Ben‐Nun, Nethanel Asher, Avichai Shimoni, Arnon Nagler, Gal Markel, Ronnie Shapira‐Frommer & Jacob Schachter. (2020) Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response. Molecular Carcinogenesis 59:7, pages 736-744.
Crossref
Anders Handrup Kverneland, Magnus Pedersen, Marie Christine Wulff Westergaard, Morten Nielsen, Troels Holz Borch, Lars Rønn Olsen, Gitte Aasbjerg, Saskia J. Santegoets, Sjoerd H. van der Burg, Katy Milne, Brad H. Nelson, Özcan Met, Marco Donia & Inge Marie Svane. (2020) Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. Oncotarget 11:22, pages 2092-2105.
Crossref
Iñaki Etxeberria, Irene Olivera, Elixabet Bolaños, Asunta Cirella, Álvaro Teijeira, Pedro Berraondo & Ignacio Melero. (2020) Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms. Cellular & Molecular Immunology 17:6, pages 576-586.
Crossref
Lana E. Kandalaft, Kunle Odunsi & George Coukos. (2020) Immune Therapy Opportunities in Ovarian Cancer. American Society of Clinical Oncology Educational Book:40, pages e228-e240.
Crossref
Olivia Le Saux, Bertrand Dubois, Marc-Henri Stern, Magali Terme, Eric Tartour, Jean-Marc Classe, Nicolas Chopin, Olivier Trédan, Christophe Caux & Isabelle Ray-Coquard. (2020) Les avancées actuelles de l’immunothérapie dans le cancer de l’ovaire. Bulletin du Cancer 107:4, pages 465-473.
Crossref
Natalia Krawczyk, Malgorzata Banys-Paluchowski, Werner Meier, Anne-Kathrin Volkmer & Tanja Fehm. (2020) Immuntherapie beim OvarialkarzinomImmunotherapy for ovarian cancer. Der Gynäkologe 53:4, pages 229-237.
Crossref
Elżbieta Chruściel, Zuzanna Urban-Wójciuk, Łukasz Arcimowicz, Małgorzata Kurkowiak, Jacek Kowalski, Mateusz Gliwiński, Tomasz Marjański, Witold Rzyman, Wojciech Biernat, Rafał Dziadziuszko, Carla Montesano, Roberta Bernardini & Natalia Marek-Trzonkowska. (2020) Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours. Cancers 12:3, pages 683.
Crossref
Christina Friese, Katja Harbst, Troels Holz Borch, Marie Christine Wulff Westergaard, Magnus Pedersen, Anders Kverneland, Göran Jönsson, Marco Donia, Inge Marie Svane & Özcan Met. (2020) CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer. Scientific Reports 10:1.
Crossref
João Manuel Santos, Camilla Heiniö, Victor Cervera-Carrascon, Dafne C A Quixabeira, Mikko Siurala, Riikka Havunen, Ralf Butzow, Sadia Zafar, Tanja de Gruijl, Heini Lassus, Anna Kanerva & Akseli Hemminki. (2020) Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity. Journal for ImmunoTherapy of Cancer 8:1, pages e000188.
Crossref
Jeffrey How, Ami Patel & Amir Jazaeri. 2020. Immunotherapy. Immunotherapy 149 182 .
Lana E. Kandalaft, Kunle Odunsi & George Coukos. (2019) Immunotherapy in Ovarian Cancer: Are We There Yet?. Journal of Clinical Oncology 37:27, pages 2460-2471.
Crossref
Eleonora Ghisoni, Martina Imbimbo, Stefan Zimmermann & Giorgio Valabrega. (2019) Ovarian Cancer Immunotherapy: Turning up the Heat. International Journal of Molecular Sciences 20:12, pages 2927.
Crossref
Thijs Roelofsen, Christina Wefers, Mark A. J. Gorris, Johannes C. Textor, Leon F. A. G. Massuger, I. Jolanda M. de Vries & Anne M. van Altena. (2018) Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report. Frontiers in Oncology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.